A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin

TerminatedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Sitaxentan sodium

Please note that this is a non-interventional study and no drug is actually given as an intervention. Instead, patients prescribed THELIN are being followed under real world circumstances. However at the request of the QA group at CT.gov, we were instructed to add sitaxentan sodium as the intervention type, regardless of the fact that this is a non-interventional study.

Trial Locations (4)

1070

Pfizer Investigational Site, Brussels

3000

Pfizer Investigational Site, Leuven

30625

Pfizer Investigational Site, Hanover

06000

Pfizer Investigational Site, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY